Lu, Y., Jin, X., Duan, C., & Chang, F. (2018). Cost-effectiveness of daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b treatment-naïve patients in China. Public Library of Science (PLoS).
Chicago ZitierstilLu, Yun, Xiuze Jin, Cheng-A-Xin Duan, und Feng Chang. Cost-effectiveness of Daclatasvir Plus Asunaprevir for Chronic Hepatitis C Genotype 1b Treatment-naïve Patients in China. Public Library of Science (PLoS), 2018.
MLA ZitierstilLu, Yun, Xiuze Jin, Cheng-A-Xin Duan, und Feng Chang. Cost-effectiveness of Daclatasvir Plus Asunaprevir for Chronic Hepatitis C Genotype 1b Treatment-naïve Patients in China. Public Library of Science (PLoS), 2018.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.